Aegerion Pharmaceuticals to Announce Second Quarter 2014 Financial Results on Tuesday, July 29
22 juil. 2014 16h00 HE
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., July 22, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
09 juil. 2014 08h30 HE
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., July 9, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
06 juin 2014 08h00 HE
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., June 6, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...
Aegerion Pharmaceuticals Announces Presentation at the Jefferies 2014 Global Healthcare Conference
28 mai 2014 08h30 HE
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 28, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
07 mai 2014 16h05 HE
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 7, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...
Aegerion Pharmaceuticals Announces First-Quarter 2014 Financial Results
06 mai 2014 16h15 HE
|
Aegerion Pharmaceuticals, Inc.
- Company achieves growth in U.S. business of 24% over prior quarter
- Cash flow positive operations anticipated in the second half of...
Aegerion Pharmaceuticals Announces Webcast of Presentations at Upcoming Investor Conferences
30 avr. 2014 16h10 HE
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...
Aegerion Pharmaceuticals to Announce First Quarter 2014 Financial Results on Tuesday, May 6
30 avr. 2014 08h30 HE
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...
Aegerion Pharmaceuticals Initiates Phase 3 Clinical Trial in Japan to Evaluate Lomitapide for Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
09 avr. 2014 08h00 HE
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 9, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of novel therapies for...
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
07 avr. 2014 16h05 HE
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 7, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...